Drug intelligence / Profile preview

difemerine

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Difemerine is a small molecule antimuscarinic agent used primarily for the symptomatic treatment of visceral spasms and gastrointestinal disorders. It acts as an antispasmodic by inhibiting muscarinic acetylcholine receptors in smooth muscle tissue of the gastrointestinal tract. This leads to relaxation of smooth muscle and relief from spasms. Like other anticholinergics, it may cause side effects such as dry mouth, dizziness, blurred vision, and drowsiness; caution is advised in patients with glaucoma or prostatic hypertrophy[2][3][4][5][6].

Brand names
Luostyl
Other names
Difemerine hydrochlorideDifemerine HCl2-(Dimethylamino)-1,1-dimethylethyl diphenylglycolate hydrochloride2-(dimethylamino)-2-methylpropyl 2-hydroxy-2,2-diphenylacetate
02

Targets

mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on difemerine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on difemerine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call